Fully updated information on diagnosis and management of IPF, including six new chapters

Includes new coverage of interstitial lung disease classification, biomarkers in IPF, new concepts in disease pathogenesis, and the genetic underpinnings of the disease

Written by an international group of expert authors

Autorentext

Keith C. Meyer, MD is a professor of pulmonary and critical care medicine at the University of Wisconsin School of Medicine and Public Health. He is volume editor of three successful Springer books: Idiopathic Pulmonary Fibrosis , Gastroesophageal Reflux and the Lung , and Bronchiolitis Obliterans Syndrome in Lung Transplantation .

Steven D. Nathan, MD is professor of medicine at Virginia Commonwealth University Inova Campus and director of the Lung Transplant and Advanced Lung Disease programs. He is also volume editor of Idiopathic Pulmonary Fibrosis and the upcoming Guide to Clinical Management of Idiopathic Pulmonary Fibrosis (with Springer Healthcare)

Inhalt

Classification and Nomenclature of Interstitial Lung Disease.- Epidemiology and Natural History of IPF.- Histopathology of IPF and Related Disorders.- Imaging of IPF.- Pulmonary Function Tests in Idiopathic Pulmonary Fibrosis.- The Role of Immunity and Inflammation in IPF Pathogenesis.- Mechanisms of Fibrosis in IPF.- The Genetics of Pulmonary Fibrosis.- Genomics and Epigenetics of Pulmonary Fibrosis.- Biomarkers and IPF.- Clinical Phenotypes and Co-morbidities in IPF.- The Keys to Making a Confident Diagnosis of IPF.- Pharmacologic Treatment of IPF.- Mimics of IPF.- Gastroesophageal Reflux and IPF.- The Role of Pulmonary Rehabilitation and Oxygen Therapy.- Acute Exacerbations of IPF.- Lung Transplantation for IPF.- Clinical Trials in IFP: What are the Best Endpoints?.- Future Directions for IPF Research.